Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers

Youyun Yang, Hailan Liu, Zhaomin Li, Zijin Zhao, Michele Yip-Schneider, Qipeng Fan, C. Schmidt, E. Gabriela Chiorean, Jingwu Xie, Liang Cheng, Jey Hsin Chen, Jian-Ting Zhang

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Human fatty acid synthase (FASN) is a homo-dimeric protein with multi-enzymatic activity responsible for the synthesis of palmitate. FASN expression has been found to be up-regulated in multiple types of human cancers and its expression correlates with poor prognosis possibly by causing treatment resistance. In this study, we tested if FASN expression is up-regulated in human pancreatic cancers and if its higher expression level in pancreatic cancers causes intrinsic resistance to gemcitabine and radiation. We found that FASN expression is significantly up-regulated in human pancreatic cancer tissues without any correlation to age, sex, race, and tumor stage. Knocking down or over-expressing FASN significantly down- or up-regulate resistance of pancreatic cancer cell lines to both gemcitabine and radiation treatments. These findings imply that the elevated FASN expression in pancreatic cancers may contribute to unsuccessful treatments of pancreatic cancers by causing intrinsic resistance to both chemotherapy and radiation therapy.

Original languageEnglish
Pages (from-to)89-98
Number of pages10
JournalInternational Journal of Biochemistry and Molecular Biology
Volume2
Issue number1
StatePublished - 2011

Fingerprint

gemcitabine
Fatty Acid Synthases
Pancreatic Neoplasms
Radiation
Chemotherapy
Palmitates
Radiotherapy
Tumors
Cells
Neoplasms
Tissue
Up-Regulation
Therapeutics
Down-Regulation
Drug Therapy
Cell Line

Keywords

  • Gemcitabine
  • Human fatty acid synthase (FASN)
  • Palmitate
  • Pancreatic cancers
  • Radiation treatments
  • Treatment resistance

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry

Cite this

Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. / Yang, Youyun; Liu, Hailan; Li, Zhaomin; Zhao, Zijin; Yip-Schneider, Michele; Fan, Qipeng; Schmidt, C.; Gabriela Chiorean, E.; Xie, Jingwu; Cheng, Liang; Chen, Jey Hsin; Zhang, Jian-Ting.

In: International Journal of Biochemistry and Molecular Biology, Vol. 2, No. 1, 2011, p. 89-98.

Research output: Contribution to journalArticle

Yang, Youyun ; Liu, Hailan ; Li, Zhaomin ; Zhao, Zijin ; Yip-Schneider, Michele ; Fan, Qipeng ; Schmidt, C. ; Gabriela Chiorean, E. ; Xie, Jingwu ; Cheng, Liang ; Chen, Jey Hsin ; Zhang, Jian-Ting. / Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers. In: International Journal of Biochemistry and Molecular Biology. 2011 ; Vol. 2, No. 1. pp. 89-98.
@article{57c84b2d559c4a048fad5388b2028711,
title = "Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers",
abstract = "Human fatty acid synthase (FASN) is a homo-dimeric protein with multi-enzymatic activity responsible for the synthesis of palmitate. FASN expression has been found to be up-regulated in multiple types of human cancers and its expression correlates with poor prognosis possibly by causing treatment resistance. In this study, we tested if FASN expression is up-regulated in human pancreatic cancers and if its higher expression level in pancreatic cancers causes intrinsic resistance to gemcitabine and radiation. We found that FASN expression is significantly up-regulated in human pancreatic cancer tissues without any correlation to age, sex, race, and tumor stage. Knocking down or over-expressing FASN significantly down- or up-regulate resistance of pancreatic cancer cell lines to both gemcitabine and radiation treatments. These findings imply that the elevated FASN expression in pancreatic cancers may contribute to unsuccessful treatments of pancreatic cancers by causing intrinsic resistance to both chemotherapy and radiation therapy.",
keywords = "Gemcitabine, Human fatty acid synthase (FASN), Palmitate, Pancreatic cancers, Radiation treatments, Treatment resistance",
author = "Youyun Yang and Hailan Liu and Zhaomin Li and Zijin Zhao and Michele Yip-Schneider and Qipeng Fan and C. Schmidt and {Gabriela Chiorean}, E. and Jingwu Xie and Liang Cheng and Chen, {Jey Hsin} and Jian-Ting Zhang",
year = "2011",
language = "English",
volume = "2",
pages = "89--98",
journal = "International Journal of Biochemistry and Molecular Biology",
issn = "2152-4114",
publisher = "e-Century Publishing Corporation",
number = "1",

}

TY - JOUR

T1 - Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers

AU - Yang, Youyun

AU - Liu, Hailan

AU - Li, Zhaomin

AU - Zhao, Zijin

AU - Yip-Schneider, Michele

AU - Fan, Qipeng

AU - Schmidt, C.

AU - Gabriela Chiorean, E.

AU - Xie, Jingwu

AU - Cheng, Liang

AU - Chen, Jey Hsin

AU - Zhang, Jian-Ting

PY - 2011

Y1 - 2011

N2 - Human fatty acid synthase (FASN) is a homo-dimeric protein with multi-enzymatic activity responsible for the synthesis of palmitate. FASN expression has been found to be up-regulated in multiple types of human cancers and its expression correlates with poor prognosis possibly by causing treatment resistance. In this study, we tested if FASN expression is up-regulated in human pancreatic cancers and if its higher expression level in pancreatic cancers causes intrinsic resistance to gemcitabine and radiation. We found that FASN expression is significantly up-regulated in human pancreatic cancer tissues without any correlation to age, sex, race, and tumor stage. Knocking down or over-expressing FASN significantly down- or up-regulate resistance of pancreatic cancer cell lines to both gemcitabine and radiation treatments. These findings imply that the elevated FASN expression in pancreatic cancers may contribute to unsuccessful treatments of pancreatic cancers by causing intrinsic resistance to both chemotherapy and radiation therapy.

AB - Human fatty acid synthase (FASN) is a homo-dimeric protein with multi-enzymatic activity responsible for the synthesis of palmitate. FASN expression has been found to be up-regulated in multiple types of human cancers and its expression correlates with poor prognosis possibly by causing treatment resistance. In this study, we tested if FASN expression is up-regulated in human pancreatic cancers and if its higher expression level in pancreatic cancers causes intrinsic resistance to gemcitabine and radiation. We found that FASN expression is significantly up-regulated in human pancreatic cancer tissues without any correlation to age, sex, race, and tumor stage. Knocking down or over-expressing FASN significantly down- or up-regulate resistance of pancreatic cancer cell lines to both gemcitabine and radiation treatments. These findings imply that the elevated FASN expression in pancreatic cancers may contribute to unsuccessful treatments of pancreatic cancers by causing intrinsic resistance to both chemotherapy and radiation therapy.

KW - Gemcitabine

KW - Human fatty acid synthase (FASN)

KW - Palmitate

KW - Pancreatic cancers

KW - Radiation treatments

KW - Treatment resistance

UR - http://www.scopus.com/inward/record.url?scp=79952136207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952136207&partnerID=8YFLogxK

M3 - Article

C2 - 21331354

AN - SCOPUS:79952136207

VL - 2

SP - 89

EP - 98

JO - International Journal of Biochemistry and Molecular Biology

JF - International Journal of Biochemistry and Molecular Biology

SN - 2152-4114

IS - 1

ER -